andrew sharp

Has grant

Senior Lecturer

University of Liverpool

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Andrew Sharp is a Senior Lecturer at the University of Liverpool in the United Kingdom. His research primarily focuses on fetal growth restriction, pregnancy-related complications, and neurodevelopmental outcomes in children. He has recently published articles exploring the economic costs of fetal growth restriction and the efficacy of sildenafil therapy in various pregnancy contexts. His work includes international surveys and comparisons of management guidelines for twin pregnancies.

Recent Grants

Grant: Close

PLANES - Placental Growth Factor Led Management of the Small for Gestational Age Fetus: a Feasibility Study.

Open Date: 2019-04-01

Close Date: 2022-12-31

Grant: Close

The modulation of p53 in correcting aberrant placental apoptosis in pre-eclampsia & intra-uterine growth restriction

Open Date: 2009-01-01

Close Date: 2010-12-31

Articles (17)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (20)

Angharad Care

NIHR Clinical Lecturer

University of Liverpool

UNITED KINGDOM

andrew sharp

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (17)

What Is the Economic Cost of FGR

Neurodevelopmental outcomes at 2 years in children who received sildenafil therapy in utero: The STRIDER randomised controlled trial

Diagnosis and management of selective fetal growth restriction in monochorionic twin pregnancies: a cross‐sectional international survey

Balancing key stakeholder priorities and ethical principles to design a trial comparing intervention or expectant management for early-onset selective fetal growth restriction in monochorionic twin pregnancy: FERN qualitative study

The efficacy of sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction: the STRIDER RCT

Nanomedicine strategies to improve therapeutic agents for the prevention and treatment of preterm birth and future directions

Comparison of international guidelines on the management of twin pregnancy

Computerized cardiotocography and Dawes–Redman criteria: how should we interpret criteria not met?

Pregnancy-Related Complications and Incidence of Atrial Fibrillation: A Systematic Review

Nanomedicine strategies to improve therapeutic agents for the prevention and treatment of preterm birth and future directions

Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy

Effectiveness of dinoprostone gel, misoprostol vaginal insert and dinoprostone vaginal insert for induction of labour in twin pregnancies

Foetal loss after chorionic villus sampling and amniocentesis in twin pregnancies: A multicentre retrospective cohort study

Making decisions about radiological imaging in pregnancy

Breast Milk Iodine Concentration (BMIC) as a Biomarker of Iodine Status in Lactating Women and Children &lt;2 Years of Age: A Systematic Review

Maternal selenium levels and whole genome screen in recurrent spontaneous preterm birth population: A nested case control study

Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis

Collaborators (20)

Angharad Care

tamara stampalija

Andrew Healey

Nathalie Auger

Ed Johnstone

Zheng Feei Ma

Jessica Liauw

Laura Goodfellow

A. Bhide

Nagendra Monangi

Kenneth I. Lim

Rebecca Spencer

Jamie Kirkham

Tom McDonald

Mark Kilby

Sarah Arrowsmith

Dominique Badr

D. O. C. Anumba

Peter von Dadelszen

Janus Christian Jakobsen

Make your next move.

Breast Milk Iodine Concentration (BMIC) as a Biomarker of Iodine Status in Lactating Women and Children <2 Years of Age: A Systematic Review